Wordt geladen...
Chronic Myelogenous Leukemia: Treatment and Monitoring
BACKGROUND: The treatment options for bcr-abl positive chronic myelogenous leukemia (CML) include chemotherapy, immune therapy, allogeneic stem cell transplantation, and molecular therapy. The tyrosine kinase inhibitor imatinib was approved for the treatment of CML in 2002. Data from clinical trials...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Deutscher Arzte Verlag
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835925/ https://ncbi.nlm.nih.gov/pubmed/20221270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2010.0114 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|